Characteristics of Cutaneous Marginal Zone Lymphomas With Marked Plasmacytic Differentiation and a T Cell

Characteristics of Cutaneous Marginal Zone Lymphomas With Marked Plasmacytic Differentiation and a T Cell–Rich Background

Published:2010-01 Issue:1 Volume:133 Page:59-69
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Geyer Julia Turbiner,Ferry Judith A.,Longtine Janina A.,Flotte Thomas J.,Harris Nancy L.,Zukerberg Lawrence R.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/133/1/59/5003899/ajcpath133-0059.pdf

Reference37 articles.

1. EXTRAMEDULLARY PLASMACYTOMA

2. Cutaneous immunocytomas: a clinicopathologic study of 26 cases

3. Stansfeld AG Diebold J Noel H Updated Kiel classification for lymphomas [letter; published correction appears in Lancet. 1988;1:372]. Lancet. 1988;1:292–293.

4. Willemze R Kerl H Sterry W EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood. 1997;90:354–371.

5. Marginal Zone Lymphoma (Low-grade B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Type) of Skin and Subcutaneous Tissue

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclin D1 expression, cell proliferation, and clonal persistence characterize primary cutaneous CD4 ⁺ small or medium T‐cell lymphoproliferative disorder;Histopathology;2022-11-18

2. Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach;Current Oncology;2022-04-24

3. Prognostic significance of Bcl-2 expression in primary cutaneous B-cell lymphoma: a reappraisal;Italian Journal of Dermatology and Venereology;2022-01

4. Cutaneous B cell lymphomas: standards in diagnostic and clinical work‐up. Hints, pitfalls and recent advances;Histopathology;2021-12-27

5. Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?;Frontiers in Oncology;2021-12-23